c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
about
P1343
A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptorAmplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factorScatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptorTargeting receptor tyrosine kinases in gastric cancerGgnbp2 Is Essential for Pregnancy Success via Regulation of Mouse Trophoblast Stem Cell Proliferation and DifferentiationDefective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.Adenovirus E1A negatively and positively modulates transcription of AP-1 dependent genes by dimer-specific regulation of the DNA binding and transactivation activities of Jun.HGF-independent potentiation of EGFR action by c-MetTruncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cells.Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.Targeted therapy in the management of advanced gastric cancer: are we making progress in the era of personalized medicine?Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene.Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice.Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer.Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factorUncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growthC-terminal truncated forms of Met, the hepatocyte growth factor receptorQuantifying single gene copy number by measuring fluorescent probe lengths on combed genomic DNA.Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis.PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor.Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor.A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation.Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling.Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture.Activated HGF-c-Met Axis in Head and Neck Cancer.Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.
P2860
Q24318269-3CF72077-D97D-4826-9D11-A4C6A24BA037Q24541450-BA37CA71-4264-4634-A093-05C41588BFCDQ24555664-F4A6D9BA-1F2E-46C3-9097-79CCDF3BF397Q24564783-81C0BE8C-7C62-434A-AF91-7D452A3E7093Q27013050-AD119206-D105-405A-95F8-15D87EB93ED3Q28509351-D6D03476-29D6-4ADD-88D9-0034CD0223C2Q33238614-C15AC59F-E12C-4198-8252-7144EBFFF67DQ33942266-7A6D6471-61BE-4CF7-89B9-A7587A18D48BQ34059438-C55BF8C3-83F0-4995-9E73-BD2FED114BCBQ35078530-49A08B34-9B31-44C8-AA2A-BA43E522EE81Q35238436-F3DCE578-675D-4C20-B869-11A7B8D416DFQ35782214-C6FA6786-C000-4AC2-92D0-45C1D9C39E14Q35863874-089EBFBC-70A1-494E-A656-693C2B46F782Q36065558-68C43093-8B23-418A-B3D3-B5AE30755DCAQ36326357-CA4208A6-213A-4DCD-B3F5-ACF51936CCDEQ36562072-3CCC65D0-3361-448E-A107-41021516C857Q36705281-1791D30D-CDF4-434C-BB72-42143BE201E7Q36734562-01EB6003-508D-48F9-A0CE-219F6FF74B21Q36743037-D568BC6A-061C-455A-B8C4-3003AE498D48Q37147856-BC5CC9DC-FD26-4C8A-B4BE-F8496454BFD9Q37175416-C485103B-1D71-4E34-83BF-0A095361F2E3Q38846778-1E8068FD-98E8-4415-9BA9-ED65854E974BQ39692077-A8E66804-0C31-4CCB-99D7-C984EEA0B790Q41596252-52A42C86-78E1-43F3-8F07-50A55E06DE1AQ41870321-4BAE1DF1-EE4D-44FA-95C5-364EAB9716DAQ41879451-270D4665-4501-48E2-8289-5E371D39EE74Q42821276-F630E9B9-53FC-443E-B95E-3BE554E88B11Q42912698-BFA1A114-C4DE-42B1-9EF9-1A74A6BFE533Q43201388-BC69405D-E186-48F2-B927-A94616A3340AQ47303095-AF5289BC-AD95-4C3C-87D4-0D8D2F38851AQ50977853-CF4C0A25-8ED2-4BB1-9285-6720E09F82C9
P2860
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
@en
type
label
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
@en
prefLabel
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
@en
P2093
P1433
P1476
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
@en
P2093
Comoglio PM
Della Valle G
Giordano S
Peverali F
Ponzetto C
P304
P407
P4510
P577
1991-04-01T00:00:00Z